PNECtumor · Mechanisms regulating pulmonary neuroendocrine cell (PNEC) growth and tumorigenesis
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2019-01-01 → 2020-12-31
- EU contribution
- €177,599
- Participants
- 1
- Scheme
- MSCA-IF-EF-ST
Lines connect the coordinator with its partners.
Results in brief
Mechanisms regulating pulmonary neuroendocrine cell (PNEC) growth and tumorigenesis
Lung neuroendocrine neoplasms (LNENs) account for 20-25% of all lung cancers and can be subdivided into high-grade carcinomas and low grade neuroendocrine tumors, carcinoids. Because they exhibit features of neuroendocrine differentiation, all LNENs are thought to arise from a rare lung cell population, called pulmonary neuroendocrine cells (PNECs). Despite their involvement in LNENs and their implication in a number of other respiratory diseases, PNECs are an understudied cell type. Their normal function is not well defined and relatively little is known about their contribution to cancer development and progression. The experiments performed for this MSCA Action were focused on the functional characterization of PNECs and the elucidation of the pathways involved in the transformation of this cell type during LNEN formation. One of the biggest barriers to studying PNECs has been the lack of tractable model systems that can be used to isolate and study this rare cell type. The objectives of the project were (1) to define PNEC heterogeneity and identify changes in gene expression associated with PNEC proliferation, (2) to define optimal conditions for PNEC expansion within a lung organoid culture system and (3) to use lung organoids to characterize key pathways involved in LNEN formation.
Data: CORDIS, © European Union
Project objective
The ultimate goal of my research is to elucidate pathways involved in lung neuroendocrine tumor (LNET) formation. LNETs arise from a rare lung cell population, called pulmonary neuroendocrine cells (PNECs) and account for 20- to 25% of all lung cancers. Despite their involvement in LNETs and a number of other respiratory diseases, relatively little is known about the normal function of PNECs or their contribution to cancer development and progression. Utilizing a novel organoid based strategy for in vitro isolation and analysis of PNECs, I will develop a model of LNE tumorigenesis with a focus on two LNET subtypes, small cell lung cancer (SCLC) and atypical carcinoids (AC). Altogether, the experiments outlined in this proposal are focused on the functional characterization of PNECs and the elucidation of the pathways involved in the transformation of this cell type during LNET formation.
Original text from CORDIS.
Participants
- KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW · AMSTERDAMCoordinatorNetherlands
Links
Data: CORDIS, © European Union
